Author

Mélanie Girard

University of TorontoORCID 0000-0002-7293-6292Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Karen K M Yeung· 1 shared Miaoxi Liu· 1 shared Nathália Vieira BatistaiD· 1 shared Sara LamorteiD· 1 shared Tania H. WattsiD· 1 shared Tianning Yu· 1 shared Tracy L. McGahaiD· 1 shared Wenting GaoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Karen K M Yeung

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity

Mélanie Girard, Tianning Yu, Nathália Vieira Batista, Karen K M Yeung, Sara Lamorte, Wenting Gao, Miaoxi Liu, Tracy L. McGaha, Tania H. Watts

This study shows STING agonists enhance anti-tumor immunity by recruiting monocytic cells and inducing IFN-I responses, with IL-18 playing a key role in CD8 T cell activation.

The Journal of Immunology · Jul 9, 2025Peer-reviewedImmunology